Supported By Join the JDD & CeraVe for this exclusive, on-demand #SkinChat webcast, where Dr. Leon H. Kircik and Professor Petra Staubach-Renz discuss the importance of adjunctive skincare solutions for…
Read More
The interest in use of medical cannabis for chronic dermatologic conditions such as psoriasis, eczema, and acne has been growing mostly owing to rapidly emerging decriminalization across the country and…
Read More
A survey was conducted at a single dermatology center to determine if there was an increased trend in cosmetic procedures in patients with moderate to severe psoriasis who attained 75%…
Read More
“Fewer people are doing mainstay full-body phototherapy as in the past, as biologics and other systemic therapies have proven to be safe and much more effective,” Dr. Nestor said in…
Read More
The May issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin Cancer, with special features on Public Health, Atopic Dermatitis, Psoriasis, and…
Read More
Psoriasis is a chronic, immune-mediated disease that mainly affects the skin and joints. Treatment for psoriasis depends on the severity, along with many other factors, and limited psoriasis can often…
Read More
New Dermatological Research is available now- view this months' JDD features, case reports, and research below: Dermatologists respond regarding the impact of COVID-19 and examine the potential impact of drugs…
Read More
iTunes Google Play Stitcher TuneIn In this edition of the JDD Podcast, Dr. Adam Friedman is joined by Dr. Deirdre Hooper, Associate Clinical Professor in the Department of Dermatology at…
Read More
The latest research in Dermatology is available online now: take a look at JDD's March 2020 content highlights: Azelaic acid 15% foam may be an efficacious therapy for rosacea while…
Read More
Psoriasis is a chronic disease that can affect many areas of the body. The use of topical corticosteroids (TCS) is a common treatment, although long-term safety of TCS remains a…
Read More
Biologics have revolutionized the treatment of psoriasis, and with new entries into the class, PASI90 and 100 have become attainable for many patients. Next Steps in Derm's most recent installment…
Read More
